Insulin glargine and cancer: another side to the story?
Gale
Edwin A M
EA
D055317:Evidence-Based Practice; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008934:Mitogens / Q000009:adverse effects; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D017712:Peer Review, Research; D012107:Research Design; D012307:Risk Factors
D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D008934:Mitogens; D000069036:Insulin Glargine